ArticleTranslational lung cancer research2024

Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study.

Clémence Pierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.